A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis. (2020)

First Author: Oliveira-Da-Silva JA
Attributed to:  VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cellimm.2020.104194

PubMed Identifier: 32827943

Publication URI: http://europepmc.org/abstract/MED/32827943

Type: Journal Article/Review

Volume: 356

Parent Publication: Cellular immunology

ISSN: 0008-8749